This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Cardiome Pharma Corp., Eprova Ag. Active years: 2001-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2017
Title: The Innovative Contributions of Martin Kurz in Schaffhausen, CH
Introduction
Martin Kurz is a distinguished inventor based in Schaffhausen, Switzerland, known for his contributions to the field of synthetic chemistry. With a portfolio of four patents, Kurz has made significant strides in the development of aminocyclohexyl ether compounds. His work showcases the intersection of innovation and practical application in the pharmaceutical and chemical industries.
Latest Patents
Kurz's most recent patents focus on a synthetic process for aminocyclohexyl ether compounds. These patents detail methods for the preparation of stereoisomerically substantial aminocyclohexyl ether compounds, including trans-(1R,2R)-aminocyclohexyl ether compounds and trans-(1S,2S)-aminocyclohexyl ether compounds. In addition to the primary compounds, Kurz also discloses various intermediates and substrates that are crucial for the synthesis. This innovative approach has implications for both fundamental research and practical applications within pharmaceuticals.
Career Highlights
Throughout his career, Kurz has worked with well-regarded organizations such as Cardiome Pharma Corp. and Eprova AG. His experiences in these companies have enabled him to refine his expertise in organic synthesis and pharmaceutical sciences, contributing to the advancement of various projects which are critical in the development of new therapeutic agents.
Collaborations
Martin Kurz has collaborated with other notable professionals in the field, such as Bertrand M. C. Plouvier and Doug Ta Hung Chou. These collaborations have fostered a rich exchange of ideas and have led to advancements in understanding and synthesizing complex compounds, including those featured in his recent patents.
Conclusion
In conclusion, Martin Kurz stands out as a significant figure in the realm of synthetic chemistry. His innovative patents focusing on aminocyclohexyl ether compounds not only highlight his expertise but also contribute to broader advancements in the field. As he continues to work and collaborate within the industry, his contributions are sure to have lasting impacts on both scientific research and pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile